Post by
antoninus on Apr 06, 2011 9:28am
Hey Launa...maybe you can address this
I know you read this so maybe you can do something to help.
Is it not possible to have a comprehensive yet simple report whereby shareholders and prospective shareholders can easily understand the many markets ISA is involved in, what the total sales are in these markets currently , what share ISA can REASONABLY expect to capture and what the net net expectations are for revenues in each of these targeted indications.
so for e.g. - isa is involved in ...
TX...trials and timelines are....with partners xyz in countries xyz...total revenues in these sectors currently is ....from that isa can expect to capture % xyz, with adoption in yr 1 to be xyz, ramping up to xyz in yr 3,5 etc...
Uveitis -
psoriasis-
stents-
tkb -
Can isa project what they HOPE will be revenues IF trials are successfully completed and what total company revenues will be in say 2012, 2013, 2014....etc...etc...
will isa potentially generate $20 million from all indications in 2015 or will they potentially generate 200 million? Is there any guidance at all which shareholders can point to?
come on guys....isnt it time this company start to market itself properly? with all the partnerships and all the trials, it seems there is a real lack of clarity on what the potential future holds and how soon it may come to pass.
Comment by
macbethorfaust on Apr 06, 2011 10:52am
the latest financial statements and MD &A does rung through where we are at; certainly a better summary than we have had in the pastobviously there are no share price expectations nor will anyone at ISA give one, but other than that I thought they did a reasonably good job this time round.
Comment by
blog on Apr 06, 2011 5:18pm
Some analyst has a $1.50 estimate on the stock; it would be interesting to see how they arrived at that number.
Comment by
throughmud on Apr 06, 2011 5:51pm
These are some good thoughts and suggestions, antoninus. mud